Data as of Apr 17
| +0.26 / +0.31%|
The 27 analysts offering 12-month price forecasts for Novartis AG have a median target of 87.78, with a high estimate of 99.18 and a low estimate of 73.73. The median estimate represents a +3.67% increase from the last price of 84.67.
The current consensus among 32 polled investment analysts is to Hold stock in Novartis AG. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.